China Health System Articles
Shanghai Pharma to acquire majority stake in China Health System for up to $600 million: GlaxoSmithKline on China hunt?
2 December 2010
Showing 1-1 of 1 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
